These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6972999)

  • 1. Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages.
    Broxmeyer HE; Bognacki J; Dorner MH; de Sousa M
    J Exp Med; 1981 Jun; 153(6):1426-44. PubMed ID: 6972999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and biochemical characterization of leukemia-associated inhibitory activity that suppresses colony and cluster formation of cells.
    Bognacki J; Broxmeyer HE; Lobue J
    Biochim Biophys Acta; 1981 Jan; 672(2):176-90. PubMed ID: 6971652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acidic isoferritins (leukemia-associated inhibitory activity) fail to inhibit blast proliferation in acute myelogenous leukemia.
    Taetle R
    Blood; 1981 Sep; 58(3):653-7. PubMed ID: 6973349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acidic and basic isoferritins on in vitro growth of human granulocyte-monocyte progenitors.
    Dezza L; Cazzola M; Piacibello W; Arosio P; Levi S; Aglietta M
    Blood; 1986 Mar; 67(3):789-95. PubMed ID: 3947747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of isoferritins on granulopoiesis.
    Sala G; Worwood M; Jacobs A
    Blood; 1986 Feb; 67(2):436-43. PubMed ID: 3942830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte-macrophage-derived acidic isoferritins: normal feedback regulators of granulocyte-macrophage progenitor cells in vitro.
    Broxmeyer HE; Bognacki J; Ralph P; Dörner MH; Lu L; Castro-Malaspina H
    Blood; 1982 Sep; 60(3):595-607. PubMed ID: 6980676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acidic isoferritins as feedback regulators in normal and leukemic myelopoiesis.
    Broxmeyer HE; Bognacki J; Dörner MH; deSousa M; Lu L
    Haematol Blood Transfus; 1981; 26():243-5. PubMed ID: 6976289
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of leukemia-associated inhibitory activity and bone marrow granulocyte-macrophage progenitor cell alterations during infection with Abelson virus.
    Broxmeyer HE; Ralph P; Gilbertson S; Margolis VB
    Cancer Res; 1980 Nov; 40(11):3928-33. PubMed ID: 6258770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production, characteristics and mode of action of hemopoietic growth inhibitors in myeloid leukemias.
    Olsson I; Olofsson T
    Med Oncol Tumor Pharmacother; 1985; 2(1):1-6. PubMed ID: 3877222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and immunological characteristics of ferritin from HL-60, U-937 and K-562 cell lines: implications for haemopoietic regulation.
    Wyllie F; Jacobs A; Waradanukul K; Worwood M; Wagstaff M
    Leuk Res; 1984; 8(6):1095-101. PubMed ID: 6546290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactoferrin, transferrin and acidic isoferritins: regulatory molecules with potential therapeutic value in leukemia.
    Broxmeyer HE; Gentile P; Bognacki J; Ralph P
    Blood Cells; 1983; 9(1):83-105. PubMed ID: 6602637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of leukemia cell-derived inhibitory activity (LIA) in conditioned media from human myeloid leukemic cell line ML-2.
    Cukrová V; Hrkal Z; Koprivová H; Neuwirt J
    Blut; 1986 Jan; 52(1):51-8. PubMed ID: 3484646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of cell-cycle expression of Ia-like antigenic determinants on normal and leukemia human granulocyte-macrophage progenitor cells to regulation in vitro by acidic isoferritins.
    Broxmeyer HE
    J Clin Invest; 1982 Mar; 69(3):632-42. PubMed ID: 6174548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoferritins in acute leukaemia.
    Cragg SJ; Jacobs A; Parry DH; Wagstaff M; Worwood M
    Br J Cancer; 1977 May; 35(5):635-42. PubMed ID: 266405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the cells in myeloid leukemia that produce leukemia associated inhibitor (LAI) and demonstration of LAI-producing cells in normal bone marrow.
    Olofsson T; Nilsson E; Olsson I
    Leuk Res; 1984; 8(3):387-96. PubMed ID: 6611459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional activities of acidic isoferritins and lactoferrin in vitro and in vivo.
    Broxmeyer HE; Gentile P; Cooper S; Lu L; Juliano L; Piacibello W; Meyers PA; Cavanna F
    Blood Cells; 1984; 10(2-3):397-426. PubMed ID: 6543656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of human tissue isoferritins.
    Wagstaff M; Worwood M; Jacobs A
    Biochem J; 1978 Sep; 173(3):969-77. PubMed ID: 708384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological reactivity of serum ferritin in patients with malignancy.
    Cazzola M; Arosio P; Bellotti V; Bergamaschi G; Dezza L; Iacobello C; Ruggeri G; Zappone E; Albertini A; Ascari E
    Tumori; 1985 Dec; 71(6):547-54. PubMed ID: 4082287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in subunit composition and iron content of isoferritins.
    Ishitani K; Listowsky I
    J Biol Chem; 1975 Jul; 250(14):5446-9. PubMed ID: 806592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities in myelopoietic regulatory interactions with acidic isoferritins and lactoferrin in mice infected with Friend virus complex: association with altered expression of Ia antigens on effector and responding cells.
    Lu L; Broxmeyer HE; Moore MA; Sheridan AP; Gentile P
    Blood; 1985 Jan; 65(1):91-9. PubMed ID: 3871166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.